The rationale behind the four major anti-COVID-19 principles of Chinese herbal medicine based on systems medicine
Guanyuan Jin, Louis Lei Jin, Bonnie Xia Jin
The rationale behind the four major anti-COVID-19 principles of Chinese herbal medicine based on systems medicine
As the novel coronavirus disease 2019 (COVID-19) and its variants continue to rage into the second year of a global pandemic, many success stories of applying Chinese herbal medicine (CHM) to treat COVID-19 patients continue to emerge from China and other part of the world. Herewith, from a systems medicine perspective, the authors analyze those experiences and categorize them into four major treatment principles: (1) focusing on eliminating toxins in the early stage of the disease, (2) tonifying deficiency of the body throughout the entire disease course, (3) treating the affected lung and intestine simultaneously based on visceral interactions, (4) cooling blood and removing blood stasis at the later stage, as well as interpret the rationale of these principles. This is helpful not only in reducing the complexity of promoting the CHM applications to enhance anti-COVID-19 efficacy, but also in ramping out the process of integrating traditional Chinese medicine with modern medical practices.
Anti-COVID-19 / Chinese herbal medicine / Systems medicine / Treatment principles / Rationale
[[1]] |
Novel coronavirus pneumonia diagnosis and treatment plan (eighth ed. trial version). Available from:
|
[[2]] |
TCM plays significant role in battle against COVID-19. Available from:
|
[[3]] |
Press conference of the State Council of China gave such comments on Chinese medicine. Available from:
|
[[4]] |
Fan AY, Gu S, Alemi SF. Chinese herbal medicine for COVID-19: current evidence with systematic review and meta-analysis. J Integr Med 2020;18(5):385-394.
|
[[5]] |
Anonymous. Inner Canon of Huangdi. Beijing: Guangling Press; 2015.
|
[[6]] |
Jin GY, Jin LL. Homeostasis, a modern elucidation of the concept of balance in traditional Chinese medicine. J Shandong Univ of Tradit Chin Med 2019;43(6):530-537.
|
[[7]] |
Jin GT, Lin F, Bao YH, et al. Principles of Systems Medicine. Beijing: World Book Press; 2019.
|
[[8]] |
Zhao HJ, Wu P, Xu WL, et al. Hippocrates Literature Collection. Beijing: Xueyuan Press; 2019.
|
[[9]] |
Shima Q. Historical Records, Biography of Bianquecang. Beijing: Zhonghua Book Co; 2009.
|
[[10]] |
Jin GY. Wellness N' Sickness - Strategies to Overcome Illnesses. Beijing: China Science and Technology Press; 2012.
|
[[11]] |
Zhou LK, Zhou Z, Jiang XM, et al. Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients. Cell Discov 2020;6(1):54.
|
[[12]] |
Zhang BL, Wang Q, Gu XH, et al. Novel Coronavirus Pneumonia: Handbook of Chinese Medicine Diagnosis and Treatment. Beijing: China Tradit Chinese Med Press; 2020.
|
[[13]] |
Liu QQ, Xia WG, An CQ, et al. Thinking of the novel coronavirus pneumonia treated with integrated traditional Chinese and Western medicine. J Tradit Chin Med 2020;61(06):1-2.
|
[[14]] |
Yu H, Li CX, Gong LT, et al. Overview of pharmacological action of glycyrrhiza. Prog Mod Biomed 2006;6(4):77-79.
|
[[15]] |
Root can be treated, even for urgent care: theory and clinical applications of “acute deficiency syndrome”. Available from:
|
[[16]] |
An X, Duan L, Zhang YH, et al. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. J Chin Med 2020;16(1):44.
|
[[17]] |
Wang J, Li F, Wei H, et al. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med 2014;211(12):2397-2410.
|
[[18]] |
Wang L, Xu MD, He YL, et al. Explanation of theory of exterior and interior relationship between lung and large intestine from the immunological view. Liaoning J Tradit Chin Med 2019;46(11):2309-2311.
|
[[19]] |
Tang L, Li SB, Yuan M, et al. Application of “lung and large intestine syndrome between exterior-interior” theory in the treatment of severe novel coronavirus pneumonia - COVID-19. J Tradit Chin Med 2020;54(4):10-13.
|
[[20]] |
WHO coronavirus disease (COVID-19) dashboard. Available from:
|
[[21]] |
Mei H, Hu Y. COVID-19 patients with novel coronavirus pneumonia: etiology, diagnosis and treatment strategies. Chin J Hematol 2020;41(3):185-191.
|
[[22]] |
Yin X, Cai SB, Tao LT, et al. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. J Integr Med 2021;19(5):460-466.
|
[[23]] |
Zhang ZJ. Treatise on Cold Pathogenic and Miscellaneous Diseases. Chongqing: Chongqing People's Press; 1955. 2.
|
[[24]] |
Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020;39(5):405-407.
|
[[25]] |
Jin GY. Systems Medicine: New Method and Protocol of Integrating East-West Medicines. Perplexities of the Modern Medicine Series (Edited by China-INI Philosophy Study Group). Beijing: Beijing Science and Technology Press; 2010. 110-128.
|
/
〈 | 〉 |